Contractor
Gilead Sciences s.r.o.
CZE / Praha - Nusle / 14000
Total awarded
€64.8M
Award notices won
19
Lots won
22
Last award
Aug 04, 2026
Awarded lots
| Lot | CPV | Contract nature | Award value | Estimated value | Place | Award criteria |
|---|---|---|---|---|---|---|
LOT-0002 / Dodávky LP s účinnou látkou SODNÁ SŮL BIKTEGRAVIRU, EMTRICITABIN, TENOFOVIR-ALAFENAMID-FUMARÁT | Pharmaceutical products | supplies | €17.4M | €17.4M | CZE | price / 100% |
LOT-0001 / LP Yescarta a Tecartus 2024 | Antineoplastic agents | supplies | €8.52M | €9.54M | CZE | price / 100% |
LOT-0002 / Dodávky LP s účinnou látkou ELVITEGRAVIR, KOBICISTAT, EMTRICITABIN, TENOFOVIR-ALAFENAMID-FUMARÁT | Pharmaceutical products | supplies | €8.13M | €8.13M | CZE | price / 100% |
LOT-0001 / Léčiva pro JIHNEM (152024) - J05AB16 REMDESIVIR | Medical preparations excluding dental consumables | supplies | €7.07M | €7.07M | CZE | price / 100% |
LOT-0002 / Dodávky LP s účinnou látkou EMTRICITABIN, TENOFOVIR-ALAFENAMID-FUMARÁT | Pharmaceutical products | supplies | €5M | €5M | CZE | price / 100% |
LOT-0001 / Část 1 | Pharmaceutical products | supplies | €4.91M | €4.91M | CZE | price / 100% |
LOT-0002 / SOFOSBUVIR,VELPATASVIR | Pharmaceutical products | supplies | €3.22M | - | CZE | price / 100% |
LOT-0001 / Léčiva pro NEMCB (082024) | Medical preparations excluding dental consumables | supplies | €2.47M | €4.07M | CZE | price / 100% |
LOT-0002 / Léčiva pro NEMCB (082024) - Část 2 J05AR20 EMTRICITABIN, TENOFOVIR-ALAFENAMID A BIKTEGRAVIR | Medical preparations excluding dental consumables | supplies | €1.69M | €1.57M | CZE | price / 100% |
LOT-0002 / Dodávky LP s účinnou látkou SOFOSBUVIR A VELPATASVIR | Pharmaceutical products | supplies | €1.6M | €1.6M | CZE | price / 100% |
Show 12 more rows
LOT-0007 / Antivirotikum s obsahem účinné látky kabotegravir | General anti-infectives for systemic use and vaccines | supplies | €1.26M | €550,715 | CZE | price / 100% |
LOT-0003 / SOFOSBUVIR,VELPATASVIR,VOXILAPREVIR | Pharmaceutical products | supplies | €1.04M | - | CZE | price / 100% |
LOT-0001 / LP s obsahem idelalisibu 2024 | Antineoplastic agents | supplies | €614,938 | €614,938 | CZE | price / 100% |
LOT-0003 / Část 3 | Pharmaceutical products | supplies | €481,055 | €802,893 | CZE | price / 100% |
LOT-0001 / Dynamický nákupní systém na dodávky léčivých přípravků | Pharmaceutical products | supplies | €474,538 | €186M | CZE | price / 100% |
LOT-0001 / Antivirotika k léčbě infekce HCV 2024 | Antivirals for systemic use | supplies | €397,064 | €397,064 | CZE | price / 100% |
LOT-0001 / J05AP55 SOFOSBUVIR A VELPATASVIR | Pharmaceutical products | supplies | €232,010 | €232,010 | CZE | price / 100% |
LOT-0001 / LP s obsahem sacituzumabu govitekan 2024 | Antineoplastic and immunomodulating agents | supplies | €187,068 | €187,068 | CZE | price / 100% |
LOT-0002 / J05AB16 REMDESIVIR | Pharmaceutical products | supplies | €113,531 | €113,470 | CZE | price / 100% |
LOT-0002 / Dodávky LP s účinnou látkou SODNÁ SŮL BIKTEGRAVIRU, EMTRICITABIN, TENOFOVIR-ALAFENAMID-FUMARÁT | Pharmaceutical products | supplies | €31,897 | €31,897 | CZE | price / 100% |
LOT-0001 / Emtricitabin, tenofovir-alafenamid a biktegravir | Antivirals for systemic use | supplies | - | - | CZE | price / 100% |
LOT-0001 / Léčivé přípravky s obsahem axikabtagen ciloleucelu - sdružený nákup | Pharmaceutical products | supplies | - | - | CZE | price / 100% |
Award tenders
| Tender | Buyer | Publication date | Procedure | Award date | Awarded to contractor | Lots won |
|---|---|---|---|---|---|---|
| Léčivé přípravky ANTIVIROTIKA 2026 II. 542234-2026 | Fakultní nemocnice Brno | Aug 04, 2026 | open | Jul 28, 2026 | €6.19M | 2 |
| Dynamický nákupní systém na dodávky léčivých přípravků 453837-2026 | Fakultní nemocnice Olomouc | Jul 01, 2026 | restricted | Jun 29, 2026 | €474,538 | 1 |
| Léčiva pro JIHNEM (152024) - J05AB16 REMDESIVIR 488668-2024 | Jihočeské nemocnice, a.s. | Aug 13, 2024 | open | Aug 11, 2024 | €7.07M | 1 |
| Léčiva pro NEMCB (082024) 501936-2024 | Nemocnice České Budějovice, a.s. | Aug 20, 2024 | open | Aug 06, 2024 | €4.17M | 2 |
| Antivirotika k léčbě infekce HCV 2024 475274-2024 | Fakultní nemocnice Olomouc | Aug 06, 2024 | open | Aug 01, 2024 | €397,064 | 1 |
| Dodávky LP s účinnou látkou SODNÁ SŮL BIKTEGRAVIRU, EMTRICITABIN, TENOFOVIR-ALAFENAMID-FUMARÁT 412933-2024 | Fakultní nemocnice Bulovka | Jul 10, 2024 | oth-single | Jul 03, 2024 | €17.4M | 1 |
| Dodávky LP s účinnou látkou SODNÁ SŮL BIKTEGRAVIRU, EMTRICITABIN, TENOFOVIR-ALAFENAMID-FUMARÁT 412477-2024 | Fakultní nemocnice Bulovka | Jul 10, 2024 | oth-single | Jul 03, 2024 | €31,897 | 1 |
| Dodávky LP s účinnou látkou ELVITEGRAVIR, KOBICISTAT, EMTRICITABIN, TENOFOVIR-ALAFENAMID-FUMARÁT 409522-2024 | Fakultní nemocnice Bulovka | Jul 09, 2024 | oth-single | Jul 03, 2024 | €8.13M | 1 |
| LP s obsahem idelalisibu 2024 409839-2024 | Fakultní nemocnice Olomouc | Jul 09, 2024 | open | Jul 03, 2024 | €614,938 | 1 |
| LP s obsahem sacituzumabu govitekan 2024 409995-2024 | Fakultní nemocnice Olomouc | Jul 09, 2024 | open | Jul 03, 2024 | €187,068 | 1 |
Show 9 more rows
| Dodávky LP s účinnou látkou SOFOSBUVIR A VELPATASVIR 407676-2024 | Fakultní nemocnice Bulovka | Jul 09, 2024 | oth-single | Jul 03, 2024 | €1.6M | 1 |
| Dodávky LP s účinnou látkou EMTRICITABIN, TENOFOVIR-ALAFENAMID-FUMARÁT 408171-2024 | Fakultní nemocnice Bulovka | Jul 09, 2024 | oth-single | Jul 03, 2024 | €5M | 1 |
| Emtricitabin, tenofovir-alafenamid a biktegravir 343681-2024 | Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha | Jun 11, 2024 | open | Jun 05, 2024 | €3.46M | 1 |
| J05AB16 REMDESIVIR 268838-2024 | Fakultní nemocnice u sv. Anny v Brně | May 07, 2024 | oth-single | May 02, 2024 | €113,531 | 1 |
| J05AP55 SOFOSBUVIR A VELPATASVIR 253462-2024 | Fakultní nemocnice u sv. Anny v Brně | Apr 29, 2024 | oth-single | Apr 21, 2024 | €232,010 | 1 |
| Léčivé přípravky s obsahem axikabtagen ciloleucelu - sdružený nákup 185012-2024 | Fakultní nemocnice Brno | Mar 27, 2024 | open | Mar 21, 2024 | €23.1M | 1 |
| Antiinfektiva 2023 143899-2024 | Fakultní nemocnice Plzeň | Mar 08, 2024 | open | Mar 05, 2024 | €3.07M | 1 |
| Antivirotika 2023 133126-2024 | Fakultní nemocnice Brno | Mar 05, 2024 | open | Feb 27, 2024 | €4.26M | 2 |
| LP Yescarta a Tecartus 2024 125759-2024 | Fakultní nemocnice Olomouc | Feb 29, 2024 | neg-wo-call | Feb 23, 2024 | €8.52M | 1 |
Company details
Identifiers
24268551
Countries
CZE
Cities
Praha - Nusle
Post codes
14000
Emails
CPV codes
Size
sme
Listed
true
About this contractor
Gilead Sciences s.r.o. is a contractor that has been awarded public procurement contracts published through official European procurement systems.
This profile summarizes publicly available procurement information, including awarded contract value, awarded lots, procurement history, countries of activity, CPV classifications, and recent contract awards.
FAQ
What information does this contractor profile contain?
This profile summarizes publicly available procurement information about the contractor, including awarded contract values, awarded lots, procurement history, CPV classifications, locations, and company details when available.
What does Total Awarded mean?
Total Awarded represents the total known value of awarded contracts associated with this contractor based on available procurement data.
Why can the awarded value differ from the total contract value?
A contractor may be awarded one or more lots within a procurement procedure. As a result, the contractor's awarded value may differ from the total value of the procurement notice.
What are Awarded Lots?
Awarded lots are individual parts of a procurement procedure that have been awarded to this contractor.
How often is this profile updated?
Contractor profiles are updated automatically when new procurement notices and contract award notices become available.
Why are some company details missing?
Contractor profiles are generated from publicly available procurement notices. Some information, such as contact details or company registration data, may not be available in every notice.
Understanding this contractor profile
This contractor profile is generated from publicly available procurement information published by contracting authorities.
The profile helps procurement professionals, suppliers, researchers, and journalists understand a contractor's participation in public procurement.
Information may include awarded contract values, awarded lots, procurement history, procurement categories (CPV), locations, and contracting authorities.